GDC--0084, page-13

we announce new collaborations each few months.

we are up 25% in the last month

we are in collaborations with the most esteemed organisations in cancer research

we have a management team looking to the mid term future over frivolous weekly announcements and we can

we are not entering into the crappy funding arrangement of companies like NOX which is tanking their SP since the announcement... looks like holders are voting with their feet.

we have an excellent science board that has pick a one in a thousand compound showing immediate interest with trial clinicians.

our compound has gained interest across the science community almost straight after we secured ownership - very astute timing on managements behalf

we have readouts from data coming through this half

we are in probably the best position of any asx listed micro cap biotech

happy to hold and acquire more